Nasdaq
ARGX
argenx SE
- Health Care
- Netherlands
- Listed 2017
- 1 day
- +0.8%
- 1 month
- −4.9%
- 1 year
- +30.0%
$875.30 · Mkt cap $54.3B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
argenx SE
$875.30 · Mkt cap $54.3B
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
argenx SE trades under the ticker ARGX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2017. Its market capitalisation is $54.3B. The last closing price was $875.30, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +30.0%, and −4.9% over the past month. Returns are price returns and exclude dividends.
This page exists because ARGX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.